F584-1325 Screening compound: ethyl 2-(4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}phenyl)acetate

F584-1325 Screening compound: ethyl 2-(4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}phenyl)acetate
F584-1325 Screening compound: ethyl 2-(4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}phenyl)acetate alternative view

Chemical Structure Depiction of ChemDiv screening compound F584-1325
ethyl 2-(4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}phenyl)acetate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F584-1325

Molecular Formula

C24H31N5O4 (C24 H31 N5 O4)

Compound Name

ethyl 2-(4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}phenyl)acetate

IUPAC name

ethyl 2-(4-{[1-methyl-3-(piperidine-1-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carbonyl]amino}phenyl)acetate

SMILES

CCOC(Cc(cc1)ccc1NC(N(CC1)Cc2c1n(C)nc2C(N1CCCCC1)=O)=O)=O

InChI

InChI=1S/C24H31N5O4/c1-3-33-21(30)15-17-7-9-18(10-8-17)25-24(32)29-14-11-20-19(16-29)22(26-27(20)2)23(31)28-12-5-4-6-13-28/h7-10H,3-6,11-16H2,1-2H3,(H,25,32)

InChI Key

QIUFZXMHGPPXCL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27177389

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.802

Distribution Coefficient, logD

1.802

Water Solubility, LogSw

-2.42

Polar Surface Area

77.194

Acid Dissociation Constant (pKa)

14.20

Base Dissociation Constant (pKb)

9.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

F584-1325 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F584-1325 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F584-1325?
Check Price and Availability of F584-1325, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F584-1325 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F584-1325
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F584-1325
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F584-1325 available by request